Literature DB >> 34426880

Semi-automated assessment of the principal diffusion direction in the corpus callosum: differentiation of idiopathic normal pressure hydrocephalus from neurodegenerative diseases.

Maria Eugenia Caligiuri1, Andrea Quattrone2, Alessandro Mechelli2, Domenico La Torre3, Aldo Quattrone4.   

Abstract

BACKGROUND: Idiopathic normal pressure hydrocephalus (iNPH) shares clinical and radiological features with progressive supranuclear palsy (PSP) and Alzheimer's disease (AD). Corpus callosum (CC) involvement in these disorders is well established on structural MRI and diffusion tensor imaging (DTI), but alterations overlap and lack specificity to underlying tissue changes.
OBJECTIVE: We propose a semi-automated approach to assess CC integrity in iNPH based on the spatial distribution of DTI-derived principal diffusion direction orientation (V1).
METHODS: We processed DTI data from 121 subjects (Site1: iNPH = 23, PSP = 27, controls = 14; ADNI: AD = 35, controls = 22) to obtain V1, fractional anisotropy (FA) and mean diffusivity (MD) maps. To increase the estimation accuracy of DTI metrics, analyses were restricted to the midsagittal CC portion (± 6 slices from midsagittal plane). Group-wise comparison of normalized altered voxel count in midsagittal CC was performed using Kruskal-Wallis tests, followed by post hoc comparisons (Bonferroni-corrected p < 0.05). ROC analysis was used to evaluate the diagnostic power of DTI alterations compared to callosal volume.
RESULTS: We found specific changes of V1 distribution in CC splenium of iNPH compared to AD and PSP, while MD and FA showed patterns of alterations common to all disorders. ROC curves showed that, compared to splenial volume, V1 represented the most accurate marker of iNPH diagnosis versus AD and PSP.
CONCLUSIONS: Our results provide evidence that V1 is a powerful biomarker for distinguishing patients with iNPH from patients with AD or PSP. Indeed, our findings also provide more specific insight into the pathophysiological mechanisms that underlie tissue damage across iNPH and its mimics.
© 2021. Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Alzheimer’s disease; Corpus callosum; Diffusion tensor imaging; Idiopathic normal pressure hydrocephalus; Principal diffusion direction; Progressive supranuclear palsy

Mesh:

Year:  2021        PMID: 34426880     DOI: 10.1007/s00415-021-10762-9

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  24 in total

1.  Cross-subject comparison of principal diffusion direction maps.

Authors:  Armin Schwartzman; Robert F Dougherty; Jonathan E Taylor
Journal:  Magn Reson Med       Date:  2005-06       Impact factor: 4.668

2.  Imaging counterpart of postural instability and vertical ocular dysfunction in patients with PSP: A multimodal MRI study.

Authors:  Andrea Quattrone; Maria Eugenia Caligiuri; Maurizio Morelli; Salvatore Nigro; Basilio Vescio; Gennarina Arabia; Giuseppe Nicoletti; Rita Nisticò; Maria Salsone; Fabiana Novellino; Gaetano Barbagallo; Maria Grazia Vaccaro; Umberto Sabatini; Virginia Vescio; Carlo Stanà; Federico Rocca; Manuela Caracciolo; Aldo Quattrone
Journal:  Parkinsonism Relat Disord       Date:  2019-02-19       Impact factor: 4.891

3.  About "axial" and "radial" diffusivities.

Authors:  Claudia A M Wheeler-Kingshott; Mara Cercignani
Journal:  Magn Reson Med       Date:  2009-05       Impact factor: 4.668

Review 4.  The role of diffusion tensor imaging and fractional anisotropy in the evaluation of patients with idiopathic normal pressure hydrocephalus: a literature review.

Authors:  Ioannis Siasios; Eftychia Z Kapsalaki; Kostas N Fountas; Aggeliki Fotiadou; Alexander Dorsch; Kunal Vakharia; John Pollina; Vassilios Dimopoulos
Journal:  Neurosurg Focus       Date:  2016-09       Impact factor: 4.047

5.  When, where, and how the corpus callosum changes in MCI and AD: a multimodal MRI study.

Authors:  M Di Paola; F Di Iulio; A Cherubini; C Blundo; A R Casini; G Sancesario; D Passafiume; C Caltagirone; G Spalletta
Journal:  Neurology       Date:  2010-04-06       Impact factor: 9.910

6.  Diffusion tensor imaging and ventricle volume quantification in patients with chronic shunt-treated hydrocephalus: a matched case-control study.

Authors:  Kristy Tan; Avital Meiri; Wenzhu B Mowrey; Rick Abbott; James T Goodrich; Adam L Sandler; Asif K Suri; Michael L Lipton; Mark E Wagshul
Journal:  J Neurosurg       Date:  2018-12-01       Impact factor: 5.115

7.  Quantitative analysis of diffusion tensor orientation: theoretical framework.

Authors:  Yu-Chien Wu; Aaron S Field; Moo K Chung; Benham Badie; Andrew L Alexander
Journal:  Magn Reson Med       Date:  2004-11       Impact factor: 4.668

8.  MR imaging index for differentiation of progressive supranuclear palsy from Parkinson disease and the Parkinson variant of multiple system atrophy.

Authors:  Aldo Quattrone; Giuseppe Nicoletti; Demetrio Messina; Francesco Fera; Francesca Condino; Pierfrancesco Pugliese; Pierluigi Lanza; Paolo Barone; Letterio Morgante; Mario Zappia; Umberto Aguglia; Olivier Gallo
Journal:  Radiology       Date:  2007-11-08       Impact factor: 11.105

9.  Automated MRI Classification in Progressive Supranuclear Palsy: A Large International Cohort Study.

Authors:  Salvatore Nigro; Angelo Antonini; David E Vaillancourt; Klaus Seppi; Roberto Ceravolo; Antonio P Strafella; Antonio Augimeri; Andrea Quattrone; Maurizio Morelli; Luca Weis; Eleonora Fiorenzato; Roberta Biundo; Roxana G Burciu; Florian Krismer; Nikolaus R McFarland; Christoph Mueller; Elke R Gizewski; Mirco Cosottini; Eleonora Del Prete; Sonia Mazzucchi; Aldo Quattrone
Journal:  Mov Disord       Date:  2020-02-24       Impact factor: 10.338

10.  Magnetic Resonance Imaging Biomarkers Distinguish Normal Pressure Hydrocephalus From Progressive Supranuclear Palsy.

Authors:  Andrea Quattrone; Alessia Sarica; Domenico La Torre; Maurizio Morelli; Basilio Vescio; Salvatore Nigro; Gaetano Barbagallo; Rita Nisticò; Maria Salsone; Pier Paolo Arcuri; Fabiana Novellino; Maria Giovanna Bianco; Gennarina Arabia; Giuseppe Cascini; Aldo Quattrone
Journal:  Mov Disord       Date:  2020-05-12       Impact factor: 10.338

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.